94
Views
38
CrossRef citations to date
0
Altmetric
Original

Effect of Treatment on Health-Related Quality of Life in Acquired Immunodeficiency Syndrome (AIDS)-Related Kaposi's Sarcoma: A Randomized Trial of Pegylated-Liposomal Doxorubicin Versus Doxorubicin, Bleomycin, and Vincristine

, , M.D., F.A.C.P., , Ph.D. & , Ph.D.
Pages 573-580 | Published online: 31 Jul 2001

REFERENCES

  • Miles S. A. Pathogenesis of AIDS-Related Kaposi's Sarcoma. Evidence of a Viral Etiology. Hematol.-Oncol. Clin. North Am. 1996; 10: 1011–1021
  • Northfelt D. W. Treatment of Kaposi's Sarcoma: Current Guidelines and Future Perspectives. Drugs 1994; 48: 569–582
  • Northfelt D. W., Dezube B. J., Thommes J. A., et al. Randomized Comparative Trial of Doxil vs. Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma (AIDS-KS). 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996, (abstract 379)
  • Northfelt D. W., Dezube B. J., Thommes J. A., Miller B. J., Fischl M. A., Friedman-Kien A., Kaplan L. D., Du Mond C., Mamelok R. D., Henry D. H. Pegylated-Liposomal Doxorubicin Versus Doxorubicin, Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma: Results of a Randomized Phase III Clinical Trial. J. Clin. Oncol. 1998; 16: 2445–2451
  • Stewart J. S.W., Jablonowski H., Goebel F. D., Arasteh K., Spittle M., Rios A., Aboulafia D., Galleshaw J., Dezube B. J. A Randomized Comparative Trial of Doxil® Versus Bleomycin and Vincristine (BV) in the Treatment of AIDS-Related Kaposi's Sarcoma. Proc. Am. Soc. Clin. Oncol. 1997; 16: 55a, (abstract 190)
  • Gill P. S., Wernz J., Myers A., et al. Liposomal Encapsulated Daunorubicin (DaunoXome®) in AIDS-Related Pulmonary Kaposi's Sarcoma. Proc. Am. Soc. Clin. Oncol. 1997; 16: 55a, (abstract 189)
  • Gill P. S., Wernz J., Scadden D. T., Cohen P., Mukwaya G. M., von Roenn J. H., Jacobs M., Kempin S., Silverberg I., Gonzales G., Rarick M. U., Myers A. M., Shepherd F., Sawka C., Pike M. C., Ross M. E. Randomized Phase III Trial of Liposomal Daunorubicin Versus Doxorubicin, Bleomycin and Vincristine in AIDS Related Kaposi's Sarcoma. J. Clin. Oncol. 1996; 14: 2353–2364
  • Mitsuyasu R., vonRoen J., Krown S., et al. Comparison Study of Liposomal Doxorubicin (DOX) Alone or with Bleomycin and Vincristine (DBV) for Treatment of Advanced AIDS-Related Kaposi's Sarcoma (AIDS-KS): AIDS Clinical Trial Group (ACTG) Protocol 286. Proc. Am. Soc. Clin. Oncol. 1997; 16: 55a, (abstract 191)
  • Goebel F. D., Goldstein D., Goos M., Jablonowski H., Stewart J. S. Efficacy and Safety of Stealth Liposomal Doxorubicin in AIDS-Related Kaposi's Sarcoma. Br. J. Cancer 1996; 73: 989–994
  • de Boer J. B., van Dam F. S.A.M., Sprangers M. A.G., Frissen P. H., Lange J. M. Longitudinal Study on the Quality of Life of Symptomatic HIV-Infected Patients in a Trial of Zidovudine Versus Zidovudine and Interferon-α. AIDS 1993; 7: 947–953
  • Lubeck D. P., Fries J. F. Changes in Quality of Life Among Patients with HIV Infection. Qual. Life Res. 1992; 1: 359–366
  • Wu A. W., Mathews W. C., Brysk L. T., Atkinson J. H., Grant I., Abramson I., Kennedy C. J., McCutchan J. A., Spector S. A., Richman D. D. Quality of Life in a Placebo-Controlled Trial of Zidovudine in Patients with AIDS and AIDS-Related Complex. J. AIDS 1990; 3: 683–690
  • Wu A. W., Rubin H. R., Mathews W. C., Ware J. E., Jr., Brysk L. T., Hardy W. D., Bozzette S. A., Spector S. A., Richman D. D. A Health Status Questionnaire Using 30 Items from the Medical Outcomes Study. Med. Care 1991; 29: 786–798
  • Osoba D., Rodrigues G., Myles J., Zee B., Pater J. Interpreting the Significance of Health-Related Quality-of-Life Scores. J. Clin. Oncol. 1998; 16: 139–144
  • King M. T. The Interpretation of Scores from the EORTC Quality of Life Questionnaire QLQ-C30. Qual. Life Res. 1996; 5: 555–567
  • Ware J. E., Kosinski M., Keller S. SF-36 Physical and Mental Summary Scales: A User's Manual. The Health Institute: New England Medical Center, Boston 1994
  • Coukell A. J., Spencer C. M. Polyethylene Glycol-Liposomal Doxorubicin. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in the Management of AIDS-Related Kaposi's Sarcoma. Drugs 1997; 53: 520–538
  • Amantea M. A., Forest A., Northfelt D. W., Mamelok R. D. Population Pharmacokinetics and Pharmacodynamics of Pegylated-Liposomal Doxorubicin with AIDS-Related Kaposi's Sarcoma. Clin. Pharmacol. Ther. 1997; 61: 301–311
  • Huisman S. J., van Dam F. S.A.M., Aaronson N. K., Hanewald G. J.F.P. On Measuring Complaints of Cancer Patients: Some Remarks on the Time Span of the Questions. The Quality of Life of Cancer Patients, N. K. Aaronson, J. Beckmann. Raven, New York 1997; 101–109
  • Pater J., Osoba D., Zee B., Lofters W., Gore M., Dempsey E., Palmer M., Chin C. Effects of Altering the Time of Administration and the Time Frame of the Quality of Life Assessments in Clinical Trials: An Example Using the EORTC QLQ-C30 in a Large Antiemetic Trial. Qual. Life Res. 1998; 7: 273–278

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.